BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4946576)

  • 1. Cellular immune responses and prognosis in malignant lymphomas.
    Sokal JE; Aungst CW
    Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
    Sokal JE
    J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
    Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
    Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 5. Delay in progression of malignant lymphoma after BCG vaccination.
    Sokal JE; Aungst CW; Snyderman M
    N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral cross immunity in patients with malignant tumors.
    Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
    [No Abstract]   [Full Text] [Related]  

  • 8. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 9. [Passive transmission of the tuberculin allergy in sarcoidosis and in malignant lymphomas].
    Kohout J
    Wien Klin Wochenschr; 1967 Oct; 79(43):795-8. PubMed ID: 4872281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of immunoglobulin in malignant lymphoma].
    Isobe T; Kato T
    Saishin Igaku; 1968 Nov; 23(11):2454-9. PubMed ID: 4180058
    [No Abstract]   [Full Text] [Related]  

  • 11. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquisitions and problems in the cellular and serum immunology of malignant blood diseases].
    CAJANO A; FAIELLA A
    Riv Emoter Immunoematol; 1960; 7():317-34. PubMed ID: 13689856
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive transfer of tuberculin sensitivity to patients with Hodgkin's disease.
    Müftüoğlu AU; Balkuv S
    N Engl J Med; 1967 Jul; 277(3):126-9. PubMed ID: 4861560
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of MP virus infection in lymphoma.
    Horton J; Hotchin JE; Olson KB; Davies JN
    Cancer Res; 1971 Aug; 31(8):1066-8. PubMed ID: 4999485
    [No Abstract]   [Full Text] [Related]  

  • 15. Reliability of histopathologic diagnosis of malignant lymphoma.
    Hakama M; Franssila K; Saxén E
    Ann Clin Res; 1973 Apr; 5(2):104-8. PubMed ID: 4584011
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
    Advani SH; Gangal SG; Gopal R; Nair CN; Dinshaw KA; Desai PB
    Indian J Med Res; 1985 Mar; 81():306-12. PubMed ID: 4018861
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease.
    Sokal JE; Aungst CW; Han T
    Int J Cancer; 1973 Jul; 12(1):242-9. PubMed ID: 4597861
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytotoxic antibodies in hematosarcomas].
    Moulinier J; Hoerni B; Merle MC; Mothey C
    Bord Med; 1972 Jun; 5(11):1291-4. PubMed ID: 4560012
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases.
    Han T
    Cancer; 1974 Feb; 33(2):497-502. PubMed ID: 4130298
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activation of the immune system and remission period in malignant lymphomas].
    Havemann K; Schultz H
    Hamatol Bluttransfus; 1976; 18():329-38. PubMed ID: 964711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.